Sherr D H, Huber B T, Gershon R K, Benacerraf B, Dorf M E
Eur J Immunol. 1981 Mar;11(3):241-6. doi: 10.1002/eji.1830110314.
The effect of anti-Lyb3 antiserum on antigen-specific B cell tolerance was investigated. The intraperitoneal injection of the nonimmunogenic copolymer L-glutamic acid60, L-lysine (GL) specifically reduces the ability of murine B cells to form GL-specific plaque-forming cell responses following challenge with the immunogenic conjugate of GL coupled to fowl gamma-globulin. It was found that this tolerance could be reversed or blocked by the intravenous injection of microliter quantities of anti-Lyb3 antiserum. However, this dose of antiserum neither reversed T cell tolerance induced with protein-coupled syngeneic erythrocytes nor induced tolerized B cells to secrete antibody. The results suggest that B lymphocytes can be rescued from GL-induced tolerance soon after induction and that Lyb3 determinants may play a functional role in the activation of antigen-specific B lymphocytes.